Login / Signup

Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients.

Mahmoud El-BendaryKhaled FaridMohammad ArafaWagdi ElkashefTalaat AbdullahAhmed El-Mesery
Published in: Journal of the Egyptian National Cancer Institute (2023)
S100A4 might be used as a prognostic marker for HCC, while GPC3 is a reliable marker of HCC diagnosis.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • hepatitis c virus
  • prognostic factors
  • human immunodeficiency virus
  • patient reported outcomes